Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
Higher Regional Court of Nuremberg: In principle, no loss of urgency due to the full utilisation of legal deadlines
Regional Court of Hamburg: Prohibition of a bonus programme for nursing staff because of violation of Section 7 para. 1 sentence 1 of the German Drug Advertising Act (HWG)
by Dr. Anja Lunze, LL.M. and Dr. Aurel-Damian Roscher, LL.M.
by Emma Allen and Andrew Spencer
by multiple authors
by Nicholas Vollers and Adrian Toutoungi
by Charlie Adams and Adrian Toutoungi
by multiple authors